7 results match your criteria: "UNC Institute for Global Health and Infectious Diseases[Affiliation]"
Front Immunol
April 2021
University of North Carolina HIV Cure Center, UNC Institute for Global Health and Infectious Diseases, Chapel Hill, NC, United States.
Quantifying the inducible HIV reservoir provides an estimate of the frequency of quiescent HIV-infected cells in humans as well as in animal models, and can help ascertain the efficacy of latency reversing agents (LRAs). The quantitative viral outgrowth assay (QVOA) is used to measure inducible, replication competent HIV and generate estimations of reservoir size. However, traditional QVOA is time and labor intensive and requires large amounts of lymphocytes.
View Article and Find Full Text PDFLancet
June 2019
Departments of Medicine, Microbiology, Immunology, and Epidemiology, and the UNC Institute for Global Health and Infectious Diseases, Chapel Hill, NC 27599-7030, USA. Electronic address:
Antivir Ther
June 2020
UNC Institute for Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Background: HIV viral load (VL) and resistance testing are limited in sub-Saharan Africa, so individuals may have prolonged time on failing first-line antiretroviral therapy (ART). Our objective was to describe the evolution of drug resistance mutations among adults failing first-line ART in Zambia.
Methods: We analysed data from a trial of VL monitoring in Lusaka, Zambia.
J Immigr Minor Health
December 2018
UNC Institute for Global Health and Infectious Diseases, Chapel Hill, NC, USA.
Stroke knowledge is poor and stroke risk is growing for the U.S. Latino immigrant population.
View Article and Find Full Text PDFContracept Reprod Med
August 2016
UNC Project-Malawi, 100 Mzimba Road, Private Bag A-104, Lilongwe, Malawi.
Background: Long-acting reversible contraception (LARC) can assist women with birth spacing and reduce unintended pregnancies. Sub-Saharan Africa has low uptake of the two available methods of LARC, the subdermal implant and intrauterine contraception (IUC). Our primary objectives were to: 1) calculate the incidence of LARC use among postpartum Malawian women, and 2) assess if LARC knowledge and intent to use LARC were associated with LARC uptake.
View Article and Find Full Text PDFAm J Public Health
June 2015
Christine U. Oramasionwu and Terence L. Johnson are with the UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill. William A. Zule is with the Substance Abuse Treatment Evaluations and Interventions Program, RTI International, Research Triangle Park, NC. Jessica Carda-Auten is with the UNC Center for AIDS Research and the UNC Institute for Global Health and Infectious Diseases, University of North Carolina, Chapel Hill. Carol E. Golin is with the Gillings School of Global Public Health and the School of Medicine, University of North Carolina, Chapel Hill.
Ongoing injection drug use contributes to the HIV and HCV epidemics in people who inject drugs. In many places, pharmacies are the primary source of sterile syringes for people who inject drugs; thus, pharmacies provide a viable public health service that reduces blood-borne disease transmission. Replacing the supply of high dead space syringes with low dead space syringes could have far-reaching benefits that include further prevention of disease transmission in people who inject drugs and reductions in dosing inaccuracies, medication errors, and medication waste in patients who use syringes.
View Article and Find Full Text PDF